Outcome of Board meeting of the Company held today i.e 13th May 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Smruthi Organics Ltd reported audited standalone financial results for FY 2025-26 with total revenue of Rs. 10,209.06 lakhs, down from Rs. 12,609.67 lakhs in the previous year (approximately 19% decline). Net profit stood at Rs. 342.57 lakhs compared to Rs. 356.29 lakhs in FY 2024-25, a decline of about 4%. The company declared a dividend of Rs. 1.50 per equity share (15%) for shareholders' approval. An exceptional item of Rs. 46.26 lakhs was recognized due to the statutory impact of new Labour Codes on gratuity. The Board also approved the appointment of Ms. Smruthi Purushotham Eaga as Whole Time Director for 3 years from June 1, 2026. Statutory auditors Gokhale & Sathe issued an unmodified (clean) opinion on the financial results.
The revenue decline of ~19% year-on-year indicates challenging market conditions for the company's bulk drugs and drug intermediates business. Despite the profit decline, the company continues to be profitable and maintains its dividend payout, which signals management confidence. The clean audit opinion and appointment of a new executive director suggest stable corporate governance.